health

New Business

China expands health insurance coverage with 91 new drugs, breakthrough treatments

China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…

Read More »
Tech

Google DeepMind unveils protein design system

Google DeepMind has unveiled an AI system called AlphaProteo that can design novel proteins that successfully bind to target molecules,…

Read More »
New Business

Li Ka-shing’s HutchMed sets up first drugs research facility in Hong Kong

HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…

Read More »
Tech

Chinese biotech sector is blowing hot as M&A and IPO deals surge amid Covid-19 pandemic

China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…

Read More »
Tech

Yifan Pharma’s unit, eyeing US$5.5 billion post-chemotherapy treatment market dominated by Amgen, considers IPO in 2021

Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…

Read More »
Tech

China’s largest e-cigarette brand Relx to study health effects of vaping amid regulatory crackdowns

The company unveiled a new bioscience laboratory on Thursday to study the health effects of vaping. The lab in Shenzhen…

Read More »
Tech

Gene editing: Chinese scientists bring safer pig-to-human organ transplants one step closer to reality

A team led by Chinese researchers say they have succeeding in producing genetically modified pigs with cells that are more…

Read More »
Tech

GeneHarbor plans Hong Kong IPO to fund new medicinal products, widen anti-ageing supplements line

The dietary supplement producer, established in 2004, spent 2 billion yuan (US$294 million) to build a factory this year in…

Read More »
Tech

Inside China Tech: Is that TikTok deal happening or not?

Beijing-based ByteDance, which has been criticised in its home market for entering negotiations with American companies soon after US President…

Read More »
Tech

Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London

Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…

Read More »
Back to top button